How we identify and treat neuromuscular toxicity induced by immune checkpoint inhibitors

Immune-related neuromuscular adverse events are rare, but potentially life-threatening side-effects of immune checkpoint inhibitors (ICIs). They usually arise within the first 3 months after initiation of ICIs. Subacute symptom onset with more rapid progression than in idiopathic autoimmune neuromus...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordan, B., Benesova, K., Hassel, J.C., Wick, W., Jordan, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637479/
https://www.ncbi.nlm.nih.gov/pubmed/34839103
http://dx.doi.org/10.1016/j.esmoop.2021.100317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637479/
https://www.ncbi.nlm.nih.gov/pubmed/34839103
http://dx.doi.org/10.1016/j.esmoop.2021.100317

Ejemplares similares